Key result
Cardiac magnetic resonance imaging provides accurate, noninvasive prognostic information about right ventricular mass, volumes, and function in patients with pulmonary arterial hypertension.
Answers are grounded in this paper and cite their sources.
CMRI is a valuable, noninvasive tool for monitoring right ventricular function and predicting long-term outcomes in patients with pulmonary arterial hypertension.
Cardiac magnetic resonance imaging (CMRI) provides accurate information about right ventricular (RV) mass, RV volumes and other markers of RV function. CMRI is proving to be a particularly useful tool in pulmonary arterial hypertension (PAH), as measures of RV function have been shown to be prognostic of long-term outcomes in this disease. Changes in RV function can also provide important information about a patient's disease course and response to treatment. As CMRI is noninvasive it can be used to regularly monitor patients with PAH, which is an important advantage over invasive right heart catheterisation. This review will explore the use of CMRI in the context of existing monitoring tools for PAH and will explore the forthcoming developments that are likely to be important in the future monitoring of patients with PAH.
No takes yet. Share an insight, caveat, or question.
Peacock et al. (2013) conducted a review in Pulmonary arterial hypertension. Cardiac magnetic resonance imaging (CMRI) vs. Echocardiography and right heart catheterization was evaluated. Cardiac magnetic resonance imaging provides accurate, noninvasive prognostic information about right ventricular mass, volumes, and function in patients with pulmonary arterial hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: